MRK Stock: Price, Earnings History and SEC Filings
Merck & Co., Inc. (MRK) last traded at $149.52, up 2.18% on the latest session and up 2.9% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $2.49 against an analyst estimate of $2.12, a beat of 17.5%.
$149.52 +2.18%
1 month+2.90%
52-week high$156.92
52-week low$82.01
Volume12.30M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MRK earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $2.49 | $2.12 | +17.45% |
| Jun 2026 | Aug 4, 2026 | $-0.13 | $-0.26 | +50.00% |
| Mar 2026 | Apr 30, 2026 | $-1.28 | $-1.51 | +15.23% |
| Dec 2025 | Feb 3, 2026 | $2.04 | $2.03 | +0.49% |
MRK beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
MRK financial history
Revenue
Net income
Free cash flow
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $65.0B | $18.3B | $12.4B | 28.1% | $7.28 |
| 2024 | $64.2B | $17.1B | $18.1B | 26.7% | $6.74 |
| 2023 | $60.1B | $365M | $9.1B | 0.6% | $0.14 |
| 2022 | $59.3B | $14.5B | $14.7B | 24.5% | $5.71 |
| 2021 | $48.7B | $13.0B | – | 26.8% | $5.14 |
| 2020 | $41.5B | $7.1B | – | 17.0% | $2.78 |
| 2019 | $39.1B | $9.8B | – | 25.2% | $3.81 |
| 2018 | $42.3B | $6.2B | – | 14.7% | $2.32 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for MRK
SEC filing data is not available right now. You can search for MRK on SEC EDGAR.
MRK news
- Merck stock rises as its cancer strategy gets personalNov 1, 2026 · thestreet.com
- MRK Q3 deep dive: oncology launches, clinical pipeline advances, and margin headwindsOct 31, 2026 · finance.yahoo.com
- How Investors Are Reacting To Moderna Stock Phase 3 Melanoma Vaccine DataOct 31, 2026 · finance.yahoo.com
- Merck (MRK) Stock Rallies As Q3 Earnings Ease Profit SqueezeOct 31, 2026 · finance.yahoo.com
- Why Merck Stock Flew Higher on FridayOct 31, 2026 · fool.com
- Eli Lilly’s Next Trillion-Dollar Opportunity May Go Beyond Weight-Loss DrugsOct 30, 2026 · 247wallst.com
- CMMB Celebrates New Distribution Center at the Brethren Service Center with Ribbon-Cutting CeremonyOct 30, 2026 · finance.yahoo.com
- This week in charts: ESMO’s winners and losersOct 30, 2026 · biopharmadive.com
About Merck & Co., Inc.
Merck & Co., Inc. (MRK) is a US-listed public company on NYSE.